Metabolites linked to renal decline, time to ESRD in T1DM

January 19, 2017

(HealthDay)—Serum levels of seven modified metabolites are associated with renal function decline and time to end-stage renal disease (ESRD) among patients with type 1 diabetes (T1D), according to a study published online Jan. 13 in Diabetes Care.

Monika A. Niewczas, M.D., Ph.D., from the Joslin Diabetes Center in Boston, and colleagues examined serum metabolomic profiles associated with variation in renal function decline in 158 patients with T1D with proteinuria and chronic kidney disease stage 3. Participants were followed for 11 years to determine the estimated slopes and to ascertain time to ESRD onset.

The researchers detected 110 amino acids and purine and pyrimidine metabolites in at least 80 percent of participants. There was an association for serum of seven modified metabolites (C-glycosyltryptophan, pseudouridine, O-sulfotyrosine, N-acetylthreonine, N-acetylserine, N6-carbamoylthreonyladenine, and N6-acetyllysine) with renal function decline and time to ESRD (P < 0.001), which was independent of relevant clinical covariates. The significant metabolites correlated with one another and with tubular injury indices.

"This prospective cohort study in participants with T1D, proteinuria, and impaired renal function at baseline demonstrated that patients with increased circulating levels of certain modified metabolites experience faster decline, leading to ESRD," the authors write. "Whether some of these candidate metabolites are risk factors or just prognostic biomarkers of progression to ESRD in T1D needs to be determined."

Explore further: Decline in eGFR mainly linear in type 1 diabetes

More information: Full Text (subscription or payment may be required)

Related Stories

Decline in eGFR mainly linear in type 1 diabetes

September 22, 2016

(HealthDay)—For patients with type 1 diabetes, the decline of estimated glomerular filtration rate (eGFR) is mainly linear, according to a study published online Sept. 19 in Diabetes Care.

Cumulative incidence of ESRD low in patients with type 1 DM

November 8, 2016

(HealthDay)—Patients with type 1 diabetes diagnosed at age 15 to 27 years have low cumulative incidence of end-stage renal disease (ESRD) and increased mortality during long-term follow-up, according to a study published ...

Study finds metabolic clues to diabetic kidney failure

January 15, 2014

About 33 percent of people with type 2 diabetes suffer kidney damage that progresses to end stage renal disease (ESRD), at which point they require either dialysis or kidney transplantation. Scientists have thought that this ...

Recommended for you

Most dengue infections transmitted in and around home

March 23, 2017

Transmission of the mosquito-borne dengue virus appears to be largely driven by infections centered in and around the home, with the majority of cases related to one another occurring in people who live less than 200 meters ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.